Camilla Qvortrup
Clinical Associate Professor
11 - 14 out of 14Page size: 10
- 2022
- Published
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact
Jacobsen, I. C., Spanggaard, I., Højgaard, M., Belcaid, L., Qvortrup, Camilla, Yde, C. W., Schmidt, A. Y., Nielsen, Finn Cilius, Willemoe, G. L., Dam, M. S., Lassen, Ulrik Niels & Staal Rohrberg, K., 2022, In: Acta Oncologica. 61, 12, p. 1499-1506 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
TP53 mutations are frequently concurrent in patients with BRAF V600E mutated solid tumors and is associated with shorter duration of response to BRAF targeted therapy
Eriksen, M., Yde, C. W., Ahlborn, L. B., Qvortrup, Camilla, Lassen, Ulrik Niels, Højgaard, M., Spanggaard, I. & Rohrberg, K. S., 2022, In: European Journal of Cancer. 174, S1, p. S118Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis
Gögenur, M., Hadi, N. A. H., Qvortrup, Camilla, Andersen, C. L. & Gögenur, Ismail, 2022, In: Annals of Surgical Oncology. 29, 13, p. 8666-8674Research output: Contribution to journal › Review › Research › peer-review
- 2021
- Published
Colorectal cancer screening in Europe: what are the next steps?
Gögenur, Ismail & Qvortrup, Camilla, 2021, In: The Lancet Oncology. 22, 7, p. 898-899 2 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
ID: 283356767